» Articles » PMID: 18284633

Role of Macrophage Infiltration in the Orbital Fat of Patients with Graves' Ophthalmopathy

Overview
Specialty Endocrinology
Date 2008 Feb 21
PMID 18284633
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Infiltration of the retro-ocular space by inflammatory cells, accumulation of glycosaminoglycans, and the overabundance of orbital adipose tissue are characteristic findings in Graves' ophthalmopathy (GO). The cause of macrophage infiltration in the orbital adipose tissue of patients with GO remains to be elucidated.

Design: Immunohistochemistry of orbital adipose tissues with anti-CD68 was used for determining macrophage infiltration pattern and cell counts. Quantitative real-time PCR was used for analysing mRNA expression. Correlation of macrophage infiltration with the duration of GO and mRNA expression were also determined.

Patients: Fifteen subjects with GO who underwent orbital decompression were recruited. Six patients without thyroid history who underwent elective orbital surgery were enrolled as controls.

Measurements: Histological distribution of macrophages, macrophage cell counts, CD68 and monocyte chemoattractant protein-1 (MCP-1) mRNA levels, and duration of GO.

Results: We demonstrated that macrophage infiltration in orbital fat from patients with GO was higher than controls (P = 0.005). The infiltration of macrophages was located primarily around blood vessels and between mature adipocytes. Macrophage infiltration did not attenuate in GO of long duration. We also found that the expression of MCP-1 was higher in GO orbital fat than that in the orbital fat of controls (P = 0.047) and the infiltration of macrophages in adipose tissue from patients with GO was positively correlated with expression of MCP-1 mRNA (r = 0.546, P = 0.035).

Conclusion: Macrophage infiltration may play an important role in the pathogenesis of GO via over-expression of MCP-1.

Citing Articles

CD169 classical monocyte as an important participant in Graves' ophthalmopathy through CXCL12-CXCR4 axis.

Wang D, Ling J, Tan R, Wang H, Qu Y, Li X iScience. 2024; 27(3):109213.

PMID: 38439953 PMC: 10910260. DOI: 10.1016/j.isci.2024.109213.


Identification of immune-related regulatory networks and diagnostic biomarkers in thyroid eye disease.

Tong X, Shen Q Int Ophthalmol. 2024; 44(1):38.

PMID: 38332455 DOI: 10.1007/s10792-024-03017-9.


Phospholipase C-γ as a Potential Therapeutic Target for Graves' Orbitopathy.

Roh T, Chae M, Ko J, Kikkawa D, Jang S, Yoon J Endocrinol Metab (Seoul). 2023; 38(6):739-749.

PMID: 37989267 PMC: 10765002. DOI: 10.3803/EnM.2023.1780.


Orbital lymphocyte populations in three states of thyroid eye disease.

Griffin S, Silkiss R Am J Ophthalmol Case Rep. 2023; 31:101865.

PMID: 37312678 PMC: 10258238. DOI: 10.1016/j.ajoc.2023.101865.


TSG6 Plays a Role in Improving Orbital Inflammatory Infiltration and Extracellular Matrix Accumulation in TAO Model Mice.

He X, Chen S, Wang X, Kong M, Shi F, Qi X J Inflamm Res. 2023; 16:1937-1948.

PMID: 37168288 PMC: 10166143. DOI: 10.2147/JIR.S409286.